NCT05493202 (SAUCE) is a clinical trial of Mira Fertility Tracker in in Vitro Fertilization, sponsored by Olive Fertility Centre.

Who is sponsoring NCT05493202?

NCT05493202 is sponsored by Olive Fertility Centre.

What drugs are being tested in NCT05493202?

Interventions in NCT05493202: Mira Fertility Tracker.

What condition does NCT05493202 study?

NCT05493202 studies in Vitro Fertilization, Hormone Testing.

Is NCT05493202 still recruiting?

NCT05493202 is currently completed. Last updated 9 August 2022.

Last reviewed 2022-08-09 · How we verify

NCT05493202: SAUCE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Superovulation And Urinary Concentration of Estrone

Completed Last updated 9 August 2022

What this trial tests

trial testing Mira Fertility Tracker in in Vitro Fertilization in 30 participants. Completed in 30 July 2022.

Timeline

20 February 2022

Primary endpoint
13 June 2022

30 July 2022

Quick facts

Lead sponsor	Olive Fertility Centre
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	20 February 2022
Primary completion	13 June 2022
Estimated completion	30 July 2022
Sites	1 location across Canada

Drugs / interventions tested

Mira Fertility Tracker

Conditions studied

in Vitro Fertilization — all drugs for in Vitro Fertilization →
Hormone Testing — all drugs for Hormone Testing →

Sponsor

Olive Fertility Centre

Who can join

Adults 21 to 45, female only, with in Vitro Fertilization or Hormone Testing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine if measurement of urinary estrone glucuronide concentrations with an at-home device is correlated with superovulatory response during gonadotropin stimulated IVF cycles.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol.
Nakhuda GS, Li N, Yang Z, Kang S. · · 2023 · cited 4× · PMID 36959966 · DOI 10.1016/j.xfre.2023.01.006

Verify or expand the search:

Other recruiting trials for in Vitro Fertilization

Currently open trials in the same condition.

NCT07020546 — Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score · NA · recruiting
NCT06604091 — Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart) · active not recruiting

Other Olive Fertility Centre trials

Trials by the same sponsor.

NCT04732013 — Noninvasive Chromosomal Screening for Embryo Selection Trial · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05493202 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Olive Fertility Centre
Last refreshed: 9 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing